Freshnews.com logo Freshnews.com 1 month ago

New Options for Treatment of RA and Lupus are Focus of Rheumatology Thought Leader Panel

-- Reactions to pivotal Phase III data supporting GlaxoSmithKline's Benlysta (belimumab) in systemic lupus erythemetosis (SLE). Full Article at Freshnews.com

Related Topics:

  1. Human Genome Sciences, Inc.
  2. US Food and Drug Administration
  3. GlaxoSmithKline Inc

Related Articles

  1. Associated Content logo
    Interview with Humorist Wanda Argersinger, Executive Director for the Lupus Support Network
    1 month ago

    I first met Wanda Argersinger at the Erma Bombeck Writer's Workshop in Dayton OH, and we had lunch with a group of other humor writers. Full Article at Associated Content

  2. Medical News Today logo
    Lupus Research Institute: Benlysta(TM) Trial Results In An Historic Research Breakthrough And Victory For People With Lupus
    1 month ago

    Main Category: Lupus Also Included In: Clinical Trials / Drug Trials Article Date: 03 Nov 2009 - 2:00 PST email to a friend printer friendly view / write opinions rate article The Lupus Research Institute (LRI) and its National Coalition of... Full Article at Medical News Today

  3. 24x7updates logo
    Lupus drug seems promising in new trial
    1 month ago

    Rockville, November 3– An experimental drug for lupus, named Benlysta, has passed the last stage of testing at a higher dose and will now be sent to the Food and Drug Administration (FDA) for its approval, Rockville-based Human Genome Sciences (HGS)... Full Article at 24x7updates

  4. PR-Inside.com logo
    Promise of a New Lupus Treatment is a Groundbreaking Achievement
    1 month ago

    2009-11-02 08:18:01 - should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA). Full Article at PR-Inside.com

View all Related Articles »

Related Quotes

  1. Combining the results of this study with the previous successful BLISS-52 study will yield a very large dataset that will allow a better understanding of lupus, the instruments to measure lupus activity, and the responses to treatment
    SOURCE: Street Insider 1 month ago
  2. We thank the hundreds of people with lupus who enrolled and took part in these important trials
    SOURCE: Street Insider 1 month ago
  3. This is a pivotal moment in lupus research
    SOURCE: Street Insider 1 month ago
(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

Browse More Photos

Daylife is the web's largest archive of news photos

  1. A general view shows the plant of Swiss pharmaceutical company Roche and the Rhine River in Basel July 20, 2009. Swiss drugmaker Roche gave a bullish forecast for the next two years after its $47 billion acquisition of Genentech and said it would expand capacity for H1N1 flu drug Tamiflu.
  2. SOUTH SAN FRANCISCO, CA - JULY 14: Pedestrians walk by a sign is displayed in front of the Genentech headquarters July 14, 2008 in South San Francisco, California.
  3. A nurse prepares a shot of the A(H1N1) vaccine (Pandemrix from Glaxo Smith Kline -GSK- laboratory) to a hospital staff member in Istanbul, on November 2, 2009.

Cast of Characters

  1. Human Genome Sciences, Inc.
  2. GlaxoSmithKline Inc GlaxoSmithKline Inc
  3. US Food and Drug Administration US Food and Drug Administration
  4. Food and Drug Administration Food and Drug Administration
  5. Erma Bombeck
  6. Department of Health Department of Health